The FDA has granted emergency use authorization for the Aptima Zika virus assay system, from Hologic, for detection of the...
Luminex Corporation has received Emergency Use Authorization (EUA) from the FDA for a multiplex nucleic acid test called the xMAP...
SARS-CoV-2 outbreak is the first pandemic of the century. SARS-CoV-2 infection is transmitted through droplets; other transmission routes are hypothesized but not confirmed.
Abbott announced that the U.S. FDA has authorised its molecular test, the Abbott RealTime ZIKA test, to detect Zika virus...
This meta-analysis aims to present a collective view on the relationship between viral infection and IPF.
Grifols announced that the FDA approved the Procleix Zika Virus assay for the detection of the virus in individual or...
Hepatitis E virus (HEV) is now recognized as a major cause of acute viral hepatitis in high-income countries, primarily due to zoonotic transmission. These EASL guidelines focus on HEV genotypes 3 and 4, offering updated recommendations for diagnosis, management, and prevention.
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory tract illness in young children and a major cause of hospital admissions globally.
The BHIVA/BASHH/BIA guideline outlines strategies to eliminate HIV transmission in the UK through expanded testing, early ART initiation, and targeted approaches based on local prevalence. It emphasizes indicator condition testing and emergency department screening.
Innovation Pharmaceuticals announced that brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral properties, is to be evaluated for its treatment potential against the monkeypox virus.